CTLA4 and neoplasm: Blockade of the function of CTLA-4 using antibodies has shown promising results regarding anti-tumor activity of T cells.33, 61 There are various studies in mice demonstrating the efficacy of anti-CTLA-4 antibodies in tumor rejection and increased immunity to tumor cells.62, 63 Based on these promising outcomes, Santulli-Marotto et al.